Nordic Life Science 1
S P E C I A L R E P O R T // S T R A T E G Y // S
C I E N C E // F I N A N C I N G EUROPE O2 O1 O3 01. UNITED KINGDOM After an “incredibly difficult time”, the life science industry in the UK is showing clear signs of renewed momentum as venture capital is edging upward and activity across the ecosystem is intensifying. READ MORE ON PAGE 46 02. THE ECOSYSTEM Geopolitical context, access to capital, operating cost, and speed will determine whether innovations will stay in Europe, according to Frédéric Druck, board member, EuropaBIO. READ MORE ON PAGE 52 03. STEM CELLS Spanish biochemist and molecular biologist Salvador Aznar Benitah’s research focuses on how adult stem cells function in normal conditions, aging, and cancer. READ MORE ON PAGE 58 O4 04. VENTURE CAPITAL Paula Pérez GonzálezAnguiano asked Cedric Moreau, Chair of the European Life Sciences Coalition, about the future of life sciences financing and investment in Europe. READ MORE ON PAGE 66 NORDICLIFESCIENCE.ORG | 45 PHOTO MASSIMILIANO MINOCRI PHOTO ISTOCK PHOTO PHOTO MAGALI DELPORTE PHOTO BENJAMIN BROLET